Summary & Overview
CPT 28072: Synovectomy, Metatarsophalangeal Joint
CPT code 28072 represents surgical synovectomy of the metatarsophalangeal joint, a targeted procedure to excise inflamed or diseased synovium in a toe joint to relieve pain and improve mobility. Nationally, this code is important for foot and ankle surgical services, affecting hospital outpatient and ambulatory surgery center billing and resource planning. It is used in clinical pathways for inflammatory arthropathies, persistent synovitis, and degenerative synovial disease when conservative care has failed.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when the procedure is indicated, typical sites of service, and an outline of commonly associated modifiers. The publication outlines benchmarking considerations for utilization and payment patterns across major payers, and notes policy and coverage themes relevant to procedural authorization and coding accuracy.
The content provides practical, concise guidance on coding intent and operational implications without clinical recommendations—helping revenue cycle, coding, and clinical teams align documentation and billing for synovectomy procedures of the metatarsophalangeal joint. Data not available in the input is noted where appropriate.
Billing Code Overview
CPT code 28072 describes a synovectomy of the metatarsophalangeal joint, a surgical procedure in which the provider removes inflamed or diseased synovial tissue from a toe joint to relieve pain and improve function.
Service Type: Surgical synovectomy
Typical Site of Service: Hospital outpatient department or ambulatory surgery center, and occasionally inpatient when medically indicated.
Clinical & Coding Specifications
Clinical Context
A 56-year-old patient with long-standing rheumatoid arthritis presents with persistent pain, swelling, and reduced range of motion of the second metatarsophalangeal joint despite optimized medical therapy and targeted injections. Conservative measures including oral anti-inflammatory medication, disease-modifying antirheumatic drugs, and a prior corticosteroid injection provided only transient relief. Imaging (weight-bearing radiographs and ultrasound or MRI) demonstrates synovial hypertrophy confined to the metatarsophalangeal joint with intact adjacent bone and no deep infection. The orthopedic or podiatric surgical team schedules an operative synovectomy of the affected metatarsophalangeal joint under regional or general anesthesia in an ambulatory surgical center or hospital outpatient setting. The procedure involves exposure of the metatarsophalangeal joint, excision of inflamed synovium, possible irrigation, and preservation of articular structures; wound closure and postoperative instructions for weight-bearing restrictions and analgesia follow. Intraoperative findings, operative time, laterality, and any additional procedures (for example, correction of associated deformity or tendon release) are documented for coding and billing. Typical payors include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA plans, and Medicare, with claims reflecting the primary procedure 28072 and appropriate modifiers for laterality, professional component, unusual services, or concurrent procedures as indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
RT |